/

Policy

The Road to Psychedelics LegalizationShutterstock

The Road to Psychedelics Legalization

Matthew X. Lowe, Ph.D., the Research Director of Unlimited Sciences, explains why observational research is the key for eventual legalization of psychedelic drugs.
When Will Psilocybin Be Available in Oregon and What's the Hold-Up?Shutterstock

When Will Psilocybin Be Available in Oregon and What’s the Hold-Up?

The Oregon Health Authority has until December 31, 2022, to finalize the framework, paving the way for licensure in early 2023.
Judge Grants Hearing for Opposition to DEA Proposal to Criminalize 5 More Psychedelics

Judge Grants Hearing for Opposition to DEA Proposal to Criminalize 5 More Psychedelics

Biotech companies and researchers opposed to five more tryptamines becoming schedule 1 controlled substances will present their case this spring.
Oregon Psilocybin Advisory Board Proposes Legalizing Just One Species of Psychedelic FungiShutterstock

Oregon Psilocybin Advisory Board Proposes Legalizing Just One Species of Psychedelic Fungi

"These fungi pose less potential safety risks to consumers," says Psilocybin Advisory Board mycologist Jessie Uehling.
Maine CDC Director Opposes Bill to Legalize Therapeutic PsilocybinShutterstock

Maine CDC Director Opposes Bill to Legalize Therapeutic Psilocybin

One of Dr. Nirav Shah's chief concerns with the bill is proposed "Psilocybin Service Centers," which he fears will lean recreational instead of medical.
How does Canada’s SAP work

How Psychedelic Treatment Through Canada’s SAP Works

Two psychedelic industry insiders reflect on the progress and flaws within Health Canada's recent amendment to the Special Access Program.
Colorado Lawmakers and Activists Push for Wide-Ranging Psychedelic ReformShutterstock

Colorado Lawmakers and Activists Push for Wide-Ranging Psychedelic Reform

Trio of lawmakers propose a psychedelic reform review panel, while two ballot initiatives push legalization and licensed "healing centers."
Oklahoma GOP Lawmakers Push for Psychedelic Medical Research and DecriminalizationShutterstock

Oklahoma GOP Lawmakers Push for Psychedelic Reform

Biggest difference between the two proposed bills: one decriminalizes plant medicine.
DEA Proposes Adding 5 Lesser-Known Psychedelics to Schedule 1 Controlled Substances

DEA Proposes Adding 5 More Psychedelics to Schedule 1 Controlled Substances

Agency argues these five tryptamines "have no known medical use," setting up a showdown with the emerging psychedelics industry.

© 2023 Psychedelic Spotlight. | Owned and operated by PSYC Media Corporation, Inc. a US publicly traded company (OTCPink: PSYC) | All Rights Reserved.